Avalyn shares in silico AP01 lung distribution modeling
Avalyn presented data at ERS Congress 2026 on AP01 lung distribution and a patient-centered pulmonary fibrosis trial design. In silico modeling predicted robust AP01 distribution in healthy and fibrotic lungs, including severe disease.